The dinucleating ligand, 2,6-bis[bis(2-pyridylmethyl)aminomethyl]-4-methylphenol](Hbpmp), formed two types of dinuclear copper(II) complexes, [Cu2(bpmp)X2]n+(X=Cl−, N3− py(pyridine), or Him(imidazole), and n=1 or 3), and [Cu2(bpmp)X]2+(X=CH3COO− or im−). On the basis of the dinucleating nature of the ligand (bpmp), the elemental analyses and the conductivity measurements in acetonitrile, it is concluded that the complexes have dimeric unit of [Cu2(bpmp)X2]n+ or [Cu2(bpmp)X]2+. In [Cu2(bpmp)X2]n+ type complexes, two copper(II) ions are linked only by a single phenolate bridge. Magnetic susceptibilities of those complexes obey Curie-Weiss law in the temperature range 80–300 K with the Weiss constants ≈−4 K, indicating that weak antiferromagnetic interactions are present in these complexes. In [Cu2[bpmp)X]2+ type complexes, however, two copper(II) ions are bridged by phenolate and acetate, or phenolate and imidazolate. Cryomagnetic measurements of the acetato and the imidazolato complexes showed antiferromagnetic interactions with the −2J values of 82 and 66 cm−1, respectively. All the complexes exhibited absorption bands at 20000–22000 cm−1 except for the azido complex. The origin of those bands are discussed.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (1984) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: